ESMAX | TRZPX | ESMAX / TRZPX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 25 years | 4 years | - |
Gain YTD | 6.394 | 8.682 | 74% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 158M | 873M | 18% |
Annual Yield % from dividends | 4.19 | 2.54 | 165% |
Returns for 1 year | 4.25 | 4.88 | 87% |
Returns for 3 years | -2.44 | 12.11 | -20% |
Returns for 5 years | 22.06 | N/A | - |
Returns for 10 years | 50.15 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BMED | 26.16 | N/A | N/A |
iShares Health Innovation Active ETF | |||
IBHI | 23.66 | -0.02 | -0.08% |
iShares iBonds 2029 Term HY & Inc ETF | |||
EWUS | 35.33 | -0.29 | -0.81% |
iShares MSCI United Kingdom Small-Cp ETF | |||
FDT | 57.64 | -0.62 | -1.07% |
First Trust Dev Mkts Ex-US AlphaDEX® ETF | |||
FDIS | 94.93 | -2.64 | -2.71% |
Fidelity MSCI Consumer Discret ETF |